Erin L Winstanley1, Yifan Zhang2, Rebecca Mashni3, Sydney Schnee4, Jonathan Penm5, Jill Boone6, Cameron McNamee7, Neil J MacKinnon6. 1. Department of Behavioral Medicine and Psychiatry, School of Medicine, West Virginia University, 930 Chestnut Ridge Road, Morgantown, WV, 26505-2854, USA. Electronic address: erin.winstanley@hsc.wvu.edu. 2. School of Pharmacy, West Virginia University, P.O. Box 9500, Morgantown, WV, 26506-9500, USA. 3. Boston University School of Law, 765 Commonwealth Avenue, Boston, MA, 02215, USA. 4. Kroger Pharmacy, Springdale, OH, USA. 5. Faculty of Pharmacy, The University of Sydney, Camperdown, NSW, Australia. 6. James L. Winkle College of Pharmacy, University of Cincinnati, 3255 Eden Avenue, Cincinnati, OH, 45267, USA. 7. State of Ohio Board of Pharmacy, 77 S. High Street, Columbus, OH, 43215, USA.
Abstract
BACKGROUND: The purpose of this study is to determine whether Ohio House Bill 341, which mandated the use of Ohio's Prescription Drug Monitoring Program (PDMP), was an effective regulatory strategy to reduce opioid and benzodiazepine dispensing. METHOD: Secondary analysis of Ohio's PDMP data on prescription opioids and benzodiazepines dispensed from November 2014 to March 2017. An interrupted time series analysis was conducted to determine if there was a significant change in the quantity of opioids and benzodiazepines dispensed. RESULTS: After HB341 became effective in April 2015, there was a statistically significant decrease in the monthly quantity (number of pills) opioids and benzodiazepines dispensed in Ohio. There was a modest increase in the mean days' supply of opioids and no change in the mean morphine equivalent dose. CONCLUSIONS: Legislation in Ohio requiring prescribers to check the PDMP was effective in reducing the quantity of opioids and benzodiazepines dispensed.
BACKGROUND: The purpose of this study is to determine whether Ohio House Bill 341, which mandated the use of Ohio's Prescription Drug Monitoring Program (PDMP), was an effective regulatory strategy to reduce opioid and benzodiazepine dispensing. METHOD: Secondary analysis of Ohio's PDMP data on prescription opioids and benzodiazepines dispensed from November 2014 to March 2017. An interrupted time series analysis was conducted to determine if there was a significant change in the quantity of opioids and benzodiazepines dispensed. RESULTS: After HB341 became effective in April 2015, there was a statistically significant decrease in the monthly quantity (number of pills) opioids and benzodiazepines dispensed in Ohio. There was a modest increase in the mean days' supply of opioids and no change in the mean morphine equivalent dose. CONCLUSIONS: Legislation in Ohio requiring prescribers to check the PDMP was effective in reducing the quantity of opioids and benzodiazepines dispensed.
Authors: Erin L Winstanley; Joe Gay; Lisa Roberts; Judi Moseley; Orman Hall; B Christine Beeghly; Theresa Winhusen; Eugene Somoza Journal: Public Health Nurs Date: 2012-08-26 Impact factor: 1.462
Authors: Joanne E Brady; Hannah Wunsch; Charles DiMaggio; Barbara H Lang; James Giglio; Guohua Li Journal: Public Health Rep Date: 2014 Mar-Apr Impact factor: 2.792
Authors: Nathaniel Katz; Brian Houle; Kathrine C Fernandez; Peter Kreiner; Cindy Parks Thomas; MeeLee Kim; Grant M Carrow; Adele Audet; David Brushwood Journal: Pain Med Date: 2008-06-28 Impact factor: 3.750
Authors: Matthew J Witry; Barbara J St Marie; Brahmendra Reddy Viyyuri; Paul D Windschitl Journal: Pain Manag Nurs Date: 2019-05-24 Impact factor: 1.929
Authors: Victor Puac-Polanco; Stanford Chihuri; David S Fink; Magdalena Cerdá; Katherine M Keyes; Guohua Li Journal: Epidemiol Rev Date: 2020-01-31 Impact factor: 6.222
Authors: Flora M Hammond; Jessica Ketchum; Kristen Dams-O'Connor; John D Corrigan; Cate Miller; Juliet Haarbauer-Krupa; Mark Faul; Lance E Trexler; Cynthia Harrison-Felix Journal: J Neurotrauma Date: 2020-07-08 Impact factor: 5.269